1832 Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-270
Closed -$30K 719
2019
Q1
$30K Sell
270
-21,930
-99% -$2.41M ﹤0.01% 531
2018
Q4
$2.14M Sell
22,200
-1,500
-6% -$159K 0.01% 337
2018
Q3
$2.89M Sell
23,700
-1,900
-7% -$224K 0.01% 339
2018
Q2
$2.81M Sell
25,600
-17,100
-40% -$1.83M 0.01% 349
2018
Q1
$4.58M Buy
42,700
+100
+0.2% +$11.1K 0.02% 297
2017
Q4
$4.53M Sell
42,600
-9,600
-18% -$1.03M 0.01% 296
2017
Q3
$5.63M Buy
52,200
+7,200
+16% +$770K 0.02% 285
2017
Q2
$4.66M Sell
45,000
-3,945
-8% -$389K 0.02% 315
2017
Q1
$4.79M Sell
48,945
-39,555
-45% -$3.79M 0.02% 324
2016
Q4
$8.09M Buy
88,500
+43,500
+97% +$3.96M 0.01% 384
2016
Q3
$4.34M Buy
45,000
+2,100
+5% +$200K 0.02% 326
2016
Q2
$3.7M Buy
+42,900
New +$3.85M 0.01% 323
2015
Q4
Sell
-357
Closed -$36K 680
2015
Q3
$36K Hold
357
﹤0.01% 509
2015
Q2
$44K Buy
+357
New +$42.7K ﹤0.01% 536
2014
Q1
Sell
-32,400
Closed -$2.46M 624
2013
Q4
$2.46M Buy
32,400
+23,925
+282% +$1.7M 0.01% 352
2013
Q3
$588K Sell
8,475
-53,325
-86% -$3.49M ﹤0.01% 350
2013
Q2
$3.58M Buy
+61,800
New +$3.57M 0.02% 297

Other funds holding IBB